Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3Gastroesophageal Reflux 2Barrett Esophagus 2Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Compression 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Non-Erosive Reflux Disease 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Hemorrhage 1Helicobacter Infections 1Head and Neck Neoplasms 1Fatigue 1Familial primary gastric lymphoma 1Delayed Bleeding 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Atrophy 1

Interventions

promestriene 1Rabeprazole 1Proton Pump Inhibitors 1Omeprazole 1Lasers, Gas 1Lasers 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Atrophy × Proton Pump Inhibitors × Clear all
NCT02407119 2023-11-09

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

National Cancer Center, Korea

Phase 3 Active not recruiting
470 enrolled
Gastrointestinal

Atrophy, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡